M. Bisceglia et al., Congenital mesoblastic nephroma: Report of a case with review of the most significant literature, PATH RES PR, 196(3), 2000, pp. 199-204
Aims and background: Congenital mesoblastic nephroma (CMN) is a rare pediat
ric tumor of the kidney with the highest peak of incidence during the first
3 postnatal months. It has previously been confused with Wilms' tumor (whi
ch, on the contrary, is rare during the first six months of age and is stil
l considered a histogenetic congener). CMN almost always has a favourable p
rognosis. Therefore, CMN needs to be correctly diagnosed and differentiated
from other pediatric renal neoplasms. Two morphological subtypes are curre
ntly distinguished histologically: the classical or leiomyomatous type and
the atypical or cellular type. Mixed forms with a combination of the two pa
tterns are also on record. Recurrence and even tumor-related death have bee
n described in the literature and always related to the atypical form or to
the mixed form, particularly in patients aged more than 3 months and in th
ose cases in which the surgical removal was not complete.
Opinions concerning post-surgical clinical management, especially in regard
to adjuvant therapy, are not unanimous.
Methods: A case of CMN, predominantly of the classical histological subtype
diagnosed in a baby with a follow-up of 6 years, is herein presented. The
tumor was discovered at birth and surgically removed after one month.
Since the tumor showed a high mitotic index (one of the characteristics of
the cellular subtype) and the perirenal fat was focally involved with the t
umor, the possibility of giving adjuvant chemotherapy was considered. Flow
cytometric analysis was also performed which showed a diploid DNA content o
f neoplastic cells.
Results: The tumor was completely removed, surgical margins were free histo
logically, and no clear-cut histological features of the atypical subtype w
ere noted. Flow cytometrically, it showed the euploid DNA content. Conseque
ntly no additional therapy was given. Six years after surgery the patient i
s developing well and is free of disease. He has regular follow-up examinat
ions. Conclusions: CMN almost always pursues a benign clinical course if di
agnosed under three months of age and if totally surgically excised indepen
dent of histological type. Criteria for management of atypical cases are no
t unanimous in regard to the benefit of additional therapy after surgery.